Selection and characterization of DNA aptamers targeting all four serotypes of dengue viruses

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Chen, Heng Li ^a   Hsiao, Wen Hsin ^a   Lee, Hsiang Chi ^a   Wu, Suh Chin ^a   Cheng, Jya Wei ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

SINGLE STRANDED DNA; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN DOMAIN III; ANTIVIRUS AGENT; APTAMER; GUANINE QUADRUPLEX; PEPTIDE FRAGMENT; VIRUS DNA;

ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DNA SEQUENCE; DNA STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FLUORESCENCE SPECTROSCOPY; G QUADRUPLEX STRUCTURE; GEL MOBILITY SHIFT ASSAY; HETERONUCLEAR SINGLE QUANTUM COHERENCE; NONHUMAN; PREDICTION; PROTEIN DNA BINDING; SITE DIRECTED MUTAGENESIS; VIRUS NEUTRALIZATION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHEMISTRY; CLASSIFICATION; DENGUE; DENGUE VIRUS; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SERODIAGNOSIS; SEROTYPE; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE; VIROLOGY;

DENGUE VIRUS GROUP; FLAVIVIRIDAE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; DENGUE; DENGUE VIRUS; DNA, VIRAL; EPITOPE MAPPING; G-QUADRUPLEXES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; SELEX APTAMER TECHNIQUE; SEQUENCE HOMOLOGY, AMINO ACID; SEROGROUP; VIRAL ENVELOPE PROTEINS;

EID: 84938334986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131240     Document Type: Article

References (49)

1. Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat Rev Microbiol. 2007; 5(7):518-28.
2. McMinn PC. The molecular basis of virulence of the encephalitogenic flaviviruses. J Gen Virol. 1997; 78 (Pt 11):2711-22.
3. Sanchez IJ, Ruiz BH. A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. J Gen Virol. 1996; 77 (Pt 10):2541-5.
4. Pokidysheva E, Zhang Y, Battisti AJ, Bator-Kelly CM, Chipman PR, Xiao C, et al. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell. 2006; 124 (3):485-93.
5. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 1995; 375(6529):291-8.
6. Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004; 427(6972):313-9.
7. Modis Y, Ogata S, Clements D, Harrison SC. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol. 2005; 79(2):1223-31.
8. Mandl CW, Allison SL, Holzmann H, Meixner T, Heinz FX. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol. 2000; 74(20):9601-9.
9. Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol. 2001; 75(16):7769-73.
10. Chu JJ, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng ML. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol. 2005; 86(Pt 2):405-12.
11. Hrobowski YM, Garry RF, Michael SF. Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J. 2005; 2:49.
12. Chin JF, Chu JJ, Ng ML. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect. 2007; 9(1):1-6.
13. Zhang ZS, Yan YS, Weng YW, Huang HL, Li SQ, He S, et al. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice. J Virol Methods. 2007; 143(2):125-31.
14. Alka, Bharati K, Malik YP, Vrati S. Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice. Med Microbiol Immunol. 2007; 196 (4):227-31.
15. Martina BE, Koraka P, van den Doel P, van Amerongen G, Rimmelzwaan GF, Osterhaus AD. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine. 2008; 26(2):153-7.
16. Sim AC, Lin W, Tan GK, Sim MS, Chow VT, Alonso S. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen. Vaccine. 2008; 26(9):1145-54. doi: 10.1016/j.vaccine.2007.12.047
17. Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol. 2008; 15(3):312-7. doi: 10.1038/nsmb.1382
18. Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, et al. A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus. J Virol. 2008; 82(14):6927-34. doi: 10.1128/JVI.02724-07
19. Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977; 146(1):201-17.
20. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998; 11(3):480-96.
21. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet. 1998; 352(9132):971-7.
22. Villar L, Dayan GH, Arredondo-Garcia JL, Rivera DM, Cunha R, Deseda C, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med. 2015; 372(2):113-23. doi: 10.1056/NEJMoa1411037
23. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990; 346(6287):818-22.
24. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249(4968):505-10.
25. Pileur F, Andreola ML, Dausse E, Michel J, Moreau S, Yamada H, et al. Selective inhibitory DNA aptamers of the human RNase H1. Nucleic Acids Res. 2003; 31(19):5776-88.
26. Mann D, Reinemann C, Stoltenburg R, Strehlitz B. In vitro selection of DNA aptamers binding ethanolamine. Biochem Biophys Res Commun. 2005; 338(4):1928-34.
27. Tang J, Yu T, Guo L, Xie J, Shao N, He Z. In vitro selection of DNA aptamer against abrin toxin and aptamer-based abrin direct detection. Biosens Bioelectron. 2007; 22(11):2456-63.
28. Chen F, Zhou J, Luo F, Mohammed AB, Zhang XL. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun. 2007; 357(3):743-8.
29. Shangguan D, Meng L, Cao ZC, Xiao Z, Fang X, Li Y, et al. Identification of liver cancer-specific aptamers using whole live cells. Anal Chem. 2008; 80(3):721-8. doi: 10.1021/ac701962v
30. Murphy MB, Fuller ST, Richardson PM, Doyle SA. An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucleic Acids Res. 2003; 31(18):e110.
31. Gopinath SC. Methods developed for SELEX. Anal Bioanal Chem. 2007; 387(1):171-82.
32. Feng XZ, Lin Z, Yang LJ, Wang C, Bai CI. Investigation of the interaction between acridine orange and bovine serum albumin. Talanta. 1998; 47(5):1223-9.
33. Huang KC, Lee MC, Wu CW, Huang KJ, Lei HY, Cheng JW. Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein. Proteins. 2008; 70(3):1116-9.
34. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967; 99(2):285-90.
35. Bauer F, Sticht H. A proline to glycine mutation in the Lck SH3-domain affects conformational sampling and increases ligand binding affinity. FEBS Lett. 2007; 581(8):1555-60.
36. Huang J, Honda W. CED: a conformational epitope database. BMC Immunology. 2006; 7.
37. Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A. 2003; 100(12):6986-91.
38. Kikin O, D'Antonio L, Bagga PS. QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res. 2006; 34(Web Server issue):W676-82.
39. Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, et al. Type-and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol. 2007; 81(23):12816-26.
40. Gromowski GD, Barrett ND, Barrett AD. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol. 2008; 82(17):8828-37. doi: 10.1128/JVI.00606-08
41. Matsui K, Gromowski GD, Li L, Schuh AJ, Lee JC, Barrett AD. Characterization of dengue complexreactive epitopes on dengue 3 virus envelope protein domain III. Virology. 2009; 384(1):16-20. doi: 10. 1016/j.virol.2008.11.013
42. Thiel K. Oligo oligarchy-The surprisingly small world of aptamers. Nat Biotechnol. 2004; 22(6):649-51.
43. Balagurumoorthy P, Brahmachari SK, Mohanty D, Bansal M, Sasisekharan V. Hairpin and parallel quartet structures for telomeric sequences. Nucleic Acids Res. 1992; 20(15):4061-7.
44. Phan AT, Kuryavyi V, Ma JB, Faure A, Andreola ML, Patel DJ. An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase. Proc Natl Acad Sci U S A. 2005; 102(3):634-9.
45. Fialova M, Kypr J, Vorlickova M. The thrombin binding aptamer GGTTGGTGTGGTTGG forms a bimolecular guanine tetraplex. Biochem Biophys Res Commun. 2006; 344(1):50-4.
46. Rujan IN, Meleney JC, Bolton PH. Vertebrate telomere repeat DNAs favor external loop propeller quadruplex structures in the presence of high concentrations of potassium. Nucleic Acids Res. 2005; 33 (6):2022-31.
47. Michalowski D, Chitima-Matsiga R, Held DM, Burke DH. Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases. Nucleic Acids Res. 2008; 36(22):7124-35. doi: 10.1093/nar/gkn891
48. Macaya RF, Schultze P, Smith FW, Roe JA, Feigon J. Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc Natl Acad Sci U S A. 1993; 90(8):3745-9.
49. Mashima T, Matsugami A, Nishikawa F, Nishikawa S, Katahira M. Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein. Nucleic Acids Res. 2009; 37(18):6249-58. doi: 10.1093/nar/gkp647